10X Genomics, Inc.(NASDAQ : TXG)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||2.23%||8.71||0.7%||$608.86m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.20%||651.88||2.7%||$494.43m|
|GILD||Gilead Sciences, Inc.||0.39%||71.61||1.0%||$434.34m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.64%||188.30||1.9%||$241.59m|
|ISEE||IVERIC bio, Inc.||1.59%||16.62||0.0%||$194.78m|
|LIFE||aTyr Pharma, Inc.||0.49%||10.31||3.2%||$144.19m|
|EXAS||EXACT Sciences Corp.||5.22%||108.15||18.1%||$135.69m|
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The companyâ€™s products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.